carbachol has been researched along with Electrocardiogram QT Prolonged in 3 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Omadacycline is a first-in-class aminomethylcycline antibiotic with a broad spectrum of activity against Gram-positive and Gram-negative aerobes and anaerobes and atypical bacterial pathogens." | 1.43 | In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline. ( Tanaka, SK; Villano, S, 2016) |
| "Probucol is a cholesterol-lowering drug that could reduce hERG current by decreasing plasma membrane hERG protein expression and eventually cause long QT syndrome." | 1.42 | Mechanisms underlying probucol-induced hERG-channel deficiency. ( Geng, HZ; Li, BX; Liu, LR; Lv, L; Shi, YQ; Yan, CC; Yan, M; Zhang, X, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, YQ | 1 |
| Yan, CC | 1 |
| Zhang, X | 1 |
| Yan, M | 1 |
| Liu, LR | 1 |
| Geng, HZ | 1 |
| Lv, L | 1 |
| Li, BX | 1 |
| Tanaka, SK | 1 |
| Villano, S | 1 |
| Fabritz, L | 1 |
| Damke, D | 1 |
| Emmerich, M | 1 |
| Kaufmann, SG | 1 |
| Theis, K | 1 |
| Blana, A | 1 |
| Fortmüller, L | 1 |
| Laakmann, S | 1 |
| Hermann, S | 1 |
| Aleynichenko, E | 1 |
| Steinfurt, J | 1 |
| Volkery, D | 1 |
| Riemann, B | 1 |
| Kirchhefer, U | 1 |
| Franz, MR | 1 |
| Breithardt, G | 1 |
| Carmeliet, E | 1 |
| Schäfers, M | 1 |
| Maier, SK | 1 |
| Carmeliet, P | 1 |
| Kirchhof, P | 1 |
3 other studies available for carbachol and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Mechanisms underlying probucol-induced hERG-channel deficiency.
Topics: Anticholesteremic Agents; Carbachol; Dose-Response Relationship, Drug; Endosomal Sorting Complexes R | 2015 |
In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline.
Topics: Animals; Anti-Bacterial Agents; Calcium Channels, L-Type; Carbachol; Cholinergic Agonists; ERG1 Pota | 2016 |
Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia A | 2010 |